314 related articles for article (PubMed ID: 15877060)
1. Gene therapy: cursed or inching towards credibility?
Branca MA
Nat Biotechnol; 2005 May; 23(5):519-21. PubMed ID: 15877060
[No Abstract] [Full Text] [Related]
2. Unlocking the money-making potential of RNAi.
Howard K
Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324
[No Abstract] [Full Text] [Related]
3. The quiet revolution.
Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
[No Abstract] [Full Text] [Related]
4. Recent patent applications in microRNAs.
Nat Biotechnol; 2006 Jan; 24(1):44. PubMed ID: 16404392
[No Abstract] [Full Text] [Related]
5. Perspectives on plasmid-based gene therapy: challenges for the product and the process.
Kelly WJ
Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):219-23. PubMed ID: 12672266
[TBL] [Abstract][Full Text] [Related]
6. How will biotechnology fare in pharma's big plan?
Nat Biotechnol; 1996 Nov; 14(11):1515. PubMed ID: 9634811
[No Abstract] [Full Text] [Related]
7. Hydrocortisone made in yeast: metabolic engineering turns a unicellular microorganism into a drug-synthesizing factory.
Dumas B; Brocard-Masson C; Assemat-Lebrun K; Achstetter T
Biotechnol J; 2006 Mar; 1(3):299-307. PubMed ID: 16897710
[TBL] [Abstract][Full Text] [Related]
8. Foundation Review: Transgenic animals and their impact on the drug discovery industry.
Dunn DA; Pinkert CA; Kooyman DL
Drug Discov Today; 2005 Jun; 10(11):757-67. PubMed ID: 15922934
[TBL] [Abstract][Full Text] [Related]
9. Chromosome engineering: prospects for gene therapy.
Grimes BR; Warburton PE; Farr CJ
Gene Ther; 2002 Jun; 9(11):713-8. PubMed ID: 12032694
[TBL] [Abstract][Full Text] [Related]
10. Genomic sciences and the medicine of tomorrow.
Drews J
Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812
[No Abstract] [Full Text] [Related]
11. A brave new medicine. A conversation with William Haseltine.. Interview by Joe Flower.
Hasetine W
Health Forum J; 1999; 42(4):28-30, 61-5. PubMed ID: 10539016
[No Abstract] [Full Text] [Related]
12. First Parkinson gene therapy trial launches.
Howard K
Nat Biotechnol; 2003 Oct; 21(10):1117-8. PubMed ID: 14520380
[No Abstract] [Full Text] [Related]
13. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
Razvi ES
IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
[No Abstract] [Full Text] [Related]
14. The end of the beginning for genomic medicine.
Bailey D; Zanders E; Dean P
Nat Biotechnol; 2001 Mar; 19(3):207-9. PubMed ID: 11231543
[No Abstract] [Full Text] [Related]
15. Boehringer networks to get ahead in gene therapy.
Johnson E
Nat Biotechnol; 1997 Jan; 15(1):12-3. PubMed ID: 9035095
[No Abstract] [Full Text] [Related]
16. The future of gene therapy in the UK.
Seymour LW
Trends Biotechnol; 2006 Aug; 24(8):347-9. PubMed ID: 16782218
[TBL] [Abstract][Full Text] [Related]
17. BIO 2006 Annual International Convention. Innovations in biotech in China and Italy.
Tear S; Zarkowska T
IDrugs; 2006 Jun; 9(6):386-9. PubMed ID: 16752303
[No Abstract] [Full Text] [Related]
18. Biotechnology consortia versus multifirm alliances: paradigm shift at work?
Persidis A; Persidis A
Nat Biotechnol; 1996 Dec; 14(13):1657-60. PubMed ID: 9634847
[No Abstract] [Full Text] [Related]
19. Editorial: between molecular and macroscopic protein engineering.
Jungbauer A
Biotechnol J; 2008 Feb; 3(2):143. PubMed ID: 18283675
[No Abstract] [Full Text] [Related]
20. [Dream or reality].
Shani M
Harefuah; 2001 Mar; 140(3):279-80. PubMed ID: 11303361
[No Abstract] [Full Text] [Related]
[Next] [New Search]
